Regora 40mg Tablet (Regorafenib) – Long Product Description

Regora 40mg Tablet (Regorafenib) is a prescription targeted anti-cancer medicine manufactured by Beacon Pharmaceuticals Limited. It contains Regorafenib 40mg, an oral multi-kinase inhibitor used to treat certain advanced cancers by blocking proteins involved in tumor growth and the formation of new blood vessels. Regora is primarily prescribed for patients with metastatic colorectal cancer (mCRC), gastrointestinal stromal tumors (GIST) that have progressed after previous therapies, and hepatocellular carcinoma (HCC) following prior treatment in eligible patients.

Each pack of Regora 40mg Tablet contains 10 tablets. The medicine is used under the supervision of an experienced oncologist, and the dosage is individualized according to the patient’s condition and treatment response.

How Regora 40mg Tablet Works

Regorafenib is an oral multi-kinase inhibitor that blocks several enzymes involved in cancer growth, including VEGFR, PDGFR, FGFR, KIT, RET, RAF, and other signaling pathways. These proteins promote tumor cell growth, blood vessel formation (angiogenesis), and cancer spread.

By inhibiting these pathways, Regora helps:

• Slow the growth of cancer cells.
• Reduce the formation of new blood vessels that nourish tumors.
• Limit the spread of cancer to other parts of the body.
• Improve disease control in eligible patients.

Uses of Regora 40mg Tablet

Regora 40mg Tablet is indicated for the treatment of:

• Metastatic Colorectal Cancer (mCRC) after failure of standard therapies.
• Advanced Gastrointestinal Stromal Tumors (GIST) following treatment with Imatinib and Sunitinib.
• Hepatocellular Carcinoma (HCC) in patients previously treated with Sorafenib.
• Other oncology indications as determined by a qualified oncologist.

Treatment should always be initiated and monitored by a cancer specialist.

Benefits of Regora 40mg Tablet

Regora offers several important therapeutic benefits, including:

• Targets multiple cancer growth pathways simultaneously.
• Helps slow the progression of advanced cancers.
• Inhibits tumor angiogenesis by blocking VEGF receptors.
• Oral tablet for convenient home administration.
• May improve overall survival in eligible patients.
• Manufactured by Beacon Pharmaceuticals Limited, a well-recognized pharmaceutical manufacturer.

Dosage and Administration

Regora 40mg Tablet should be taken exactly as prescribed by an oncologist.

The standard treatment regimen usually consists of:

• 160mg once daily (four 40mg tablets) for 21 consecutive days, followed by 7 days without treatment, completing a 28-day treatment cycle.

The tablets should be taken after a low-fat meal at approximately the same time each day. Swallow the tablets whole with water without crushing or chewing them.

Routine monitoring of liver function, blood pressure, complete blood counts, and overall clinical response is recommended throughout treatment.

Possible Side Effects

Like all targeted cancer medicines, Regora may cause side effects.

Common side effects include:

• Fatigue
• Diarrhea
• Loss of appetite
• Weight loss
• High blood pressure
• Hoarseness
• Hand-foot skin reaction (palmar-plantar erythrodysesthesia)
• Mouth sores
• Nausea
• Rash

Serious side effects may include:

• Severe liver toxicity
• Gastrointestinal bleeding
• Gastrointestinal perforation
• Heart problems
• Severe hypertension
• Blood clots
• Delayed wound healing
• Serious infections
• Severe allergic reactions

Patients should seek immediate medical attention if they experience severe abdominal pain, yellowing of the skin or eyes, heavy bleeding, chest pain, sudden shortness of breath, or severe skin reactions.

Precautions and Warnings

Before taking Regora 40mg Tablet, inform your doctor if you have:

• Liver disease
• Heart disease
• High blood pressure
• Bleeding disorders
• Kidney disease
• Recent surgery or planned surgery
• Pregnancy or plans to become pregnant
• Breastfeeding

Blood pressure and liver function should be monitored regularly throughout therapy.

Women and men should use effective contraception during treatment and for the recommended period after the last dose.

Storage Information

Store Regora 40mg Tablets at room temperature below 30°C, protected from moisture, heat, and direct sunlight. Keep the tablets in their original container and out of the reach of children.

Why Buy Regora 40mg Tablet from MedicineWalyDost?

At MedicineWalyDost, we provide genuine targeted oncology medicines sourced from trusted pharmaceutical manufacturers. Regora 40mg Tablet by Beacon Pharmaceuticals Limited is available with reliable nationwide delivery across Pakistan for oncology hospitals, clinics, and individual patients.

When you order from MedicineWalyDost, you receive:

• Genuine oncology medicines
• Competitive pricing
• Nationwide delivery across Pakistan
• Secure packaging
• Professional customer support
• Assistance with medicine availability and ordering

Note: A valid prescription from a qualified oncologist is required before purchasing Regora 40mg Tablet.

---

Frequently Asked Questions (FAQs)

What is Regora 40mg Tablet used for?

Regora 40mg Tablet is used to treat metastatic colorectal cancer (mCRC), advanced gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC) in eligible patients after previous treatments.

Who manufactures Regora 40mg Tablet?

Regora 40mg Tablet is manufactured by Beacon Pharmaceuticals Limited.

What is the pack size?

Each pack contains 10 tablets.

How should Regora be taken?

It is generally taken once daily after a low-fat meal for 21 consecutive days, followed by 7 days off treatment, or exactly as prescribed by your oncologist.

Is a prescription required?

Yes. Regora 40mg Tablet is a prescription-only targeted oncology medicine and should only be used under the supervision of a qualified oncologist.

Alternate Products

Regocent 40mg Tablet (Regorafenib)

Reganni 40mg Tablet (Regorafenib)